Interesting beginning to 201410 Jan 2014 14:28
YORK, 19 December 2013 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Group"), the regenerative medical devices company, today announces that Antony Odell, Managing Director of Tissue Regenix, will be attending the 32nd Annual J.P. Morgan Healthcare Conference, to be held on 13-16 January in San Francisco.
With the aim of targeting all the states within the US, Tissue Regenix intends to sign further distribution agreements to ensure sales coverage exists in all US metropolitan areas by the end 2014. DermaPure™ also remains on course for its commercial launch in the US during the first three months of 2014.